294 related articles for article (PubMed ID: 8981920)
1. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m.
Khare SD; Hansen J; Luthra HS; David CS
J Clin Invest; 1996 Dec; 98(12):2746-55. PubMed ID: 8981920
[TBL] [Abstract][Full Text] [Related]
2. Development of spontaneous arthritis in beta2-microglobulin-deficient mice without expression of HLA-B27: association with deficiency of endogenous major histocompatibility complex class I expression.
Kingsbury DJ; Mear JP; Witte DP; Taurog JD; Roopenian DC; Colbert RA
Arthritis Rheum; 2000 Oct; 43(10):2290-6. PubMed ID: 11037889
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides.
Khare SD; Bull MJ; Hanson J; Luthra HS; David CS
J Immunol; 1998 Jan; 160(1):101-6. PubMed ID: 9551961
[TBL] [Abstract][Full Text] [Related]
4. Similar cell surface expression of beta2-microglobulin-free heavy chains by HLA-B27 subtypes differentially associated with ankylosing spondylitis.
Vázquez MN; López de Castro JA
Arthritis Rheum; 2005 Oct; 52(10):3290-9. PubMed ID: 16200602
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies.
Khare SD; Luthra HS; David CS
J Exp Med; 1995 Oct; 182(4):1153-8. PubMed ID: 7561688
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the mystery of HLA-B27 association with human spondyloarthropathies using transgenic and knock out mice.
Khare SD; Luthra HS; David CS
Semin Immunol; 1998 Feb; 10(1):15-23. PubMed ID: 9529652
[TBL] [Abstract][Full Text] [Related]
7. Peptide binding alpha1alpha2 domain of HLA-B27 contributes to the disease pathogenesis in transgenic mice.
Khare SD; Lee S; Bull MJ; Hanson J; Luthra HS; Hammerling GJ; David CS
Hum Immunol; 1999 Feb; 60(2):116-26. PubMed ID: 10027779
[TBL] [Abstract][Full Text] [Related]
8. Arthritis in HLA-B27 transgenic animals.
Taurog JD
Am J Med Sci; 1998 Oct; 316(4):250-6. PubMed ID: 9766486
[TBL] [Abstract][Full Text] [Related]
9. HLA-B27 transgenic mice are susceptible to collagen-induced arthritis: type II collagen as a potential target in human disease.
Lee S; Khare SD; Griffiths MM; Luthra HS; David CS
Hum Immunol; 2000 Feb; 61(2):140-7. PubMed ID: 10717806
[TBL] [Abstract][Full Text] [Related]
10. Strong association of HLA-B27 heavy chain with beta 2-microglobulin.
Tran TM; Horejsí V; Weinreich S; Pla M; Breur BS; Capková J; Flieger M; Ivanyi P; Ivasková E
Hum Immunol; 2000 Dec; 61(12):1197-201. PubMed ID: 11163075
[TBL] [Abstract][Full Text] [Related]
11. Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice.
Pacasova R; Martinozzi S; Boulouis HJ; Ulbrecht M; Vieville JC; Sigaux F; Weiss EH; Pla M
J Immunol; 1999 May; 162(9):5190-6. PubMed ID: 10227992
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous inflammatory disease in HLA-B27 transgenic mice does not require transporter of antigenic peptides.
Khare SD; Lee S; Bull MJ; Hanson J; Luthra HS; David CS
Clin Immunol; 2001 Mar; 98(3):364-9. PubMed ID: 11237560
[TBL] [Abstract][Full Text] [Related]
13. The epitope recognized by pan-HLA class I-reactive monoclonal antibody W6/32 and its relationship to unusual stability of the HLA-B27/beta2-microglobulin complex.
Tran TM; Ivanyi P; Hilgert I; Brdicka T; Pla M; Breur B; Flieger M; Ivasková E; Horejsí V
Immunogenetics; 2001 Aug; 53(6):440-6. PubMed ID: 11685454
[TBL] [Abstract][Full Text] [Related]
14. What is the role of HLA-B27 in spondyloarthropathies?
Chatzikyriakidou A; Voulgari PV; Drosos AA
Autoimmun Rev; 2011 Jun; 10(8):464-8. PubMed ID: 21296192
[TBL] [Abstract][Full Text] [Related]
15. Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats.
Tran TM; Dorris ML; Satumtira N; Richardson JA; Hammer RE; Shang J; Taurog JD
Arthritis Rheum; 2006 Apr; 54(4):1317-27. PubMed ID: 16575857
[TBL] [Abstract][Full Text] [Related]
16. HLA-B27 lacking associated beta2-microglobulin rearranges to auto-display or cross-display residues 169-181: a novel molecular mechanism for spondyloarthropathies.
Luthra-Guptasarma M; Singh B
FEBS Lett; 2004 Sep; 575(1-3):1-8. PubMed ID: 15388324
[TBL] [Abstract][Full Text] [Related]
17. HLA-B27 in inbred and non-inbred transgenic mice. Cell surface expression and recognition as an alloantigen in the absence of human beta 2-microglobulin.
Taurog JD; Lowen L; Forman J; Hammer RE
J Immunol; 1988 Dec; 141(11):4020-3. PubMed ID: 3053904
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure.
Allen RL; O'Callaghan CA; McMichael AJ; Bowness P
J Immunol; 1999 May; 162(9):5045-8. PubMed ID: 10227970
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mice expressing human HLA and CD8 molecules generate HLA-restricted measles virus cytotoxic T lymphocytes of the same specificity as humans with natural measles virus infection.
Tishon A; LaFace DM; Lewicki H; van Binnendijk RS; Osterhaus A; Oldstone MB
Virology; 2000 Sep; 275(2):286-93. PubMed ID: 10998329
[TBL] [Abstract][Full Text] [Related]
20. Expression of HLA class I molecules assembled with structural variants of human beta2-microglobulin.
Trymbulak WP; Zeff RA
Immunogenetics; 1997; 46(5):418-26. PubMed ID: 9271632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
